masterThesis
Gastos públicos com medicamentos judicializados no Rio Grande do Norte nos anos de 2016 e 2017
Fecha
2018-07-30Registro en:
BRAGA, Bárbara Suellen Fonseca. Gastos públicos com medicamentos judicializados no Rio Grande do Norte nos anos de 2016 e 2017. 2018. 63f. Dissertação (Mestrado em Saúde Coletiva) - Centro de Ciências da Saúde, Universidade Federal do Rio Grande do Norte, Natal, 2018.
Autor
Braga, Bárbara Suellen Fonseca
Resumen
The judicialization of health is a phenomenon that began in Brazil after the Federal
Constitution of 1988. This type of lawsuit has been growing in quantity every year and
requests from beds of intensive therapy to medicines. When it has as requested the Public
Power ends directly affect the financing of public health. For this reason, the processes of
judicialization of medicines reach several public health policies, mainly the policies of access
to medicines, and of financing. The objective of this article is to characterize the legal claims
for medicines in the State of Rio Grande do Norte in relation to the financial aspect in the
years 2016 and 2017. This is a mixed study, since an integrative review was elaborated on the
expenses with the judicialization of drugs, and an exploratory descriptive study on the public
expenditures with judicialized medicines in the State of Rio Grande do Norte. The first study
analyzed 857 scientific articles, at the end of which 9 articles were included, all of which
investigated Brazilian judicial processes, most of them concentrated in the southern and
southeastern regions of Brazil, and set up expenditures between 350,000 and 219 million
reais. The second study analyzed 370 individual lawsuits in 2016 and 2017, requesting
medicines, moved in the State of Rio Grande do Norte. The amounts spent on the
judicialization of medicines in these years were R $ 10,687,951.09. 572 drugs were required,
61.36% of which were outside National Drug List (RENAME) and the most demanded type
of drug were antineoplastic agents and immunomodulators (24.13%). The purchase was made
by the patient in 75.81% of the cases from the release of a court order. Thus, the
judicialization of medicines in a small state causes iniquities in the access of users of the
Brazilian Health System (SUS) to medicines and in the financing of Pharmaceutical
Assistance.